Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Biosino Bio-Technology and Science Gross Margin %?
Biosino Bio-Technology and ScienceHKSE:08247 -0.16%37 Gross Margin % is 37.91% as of Dec. 2025, which is 8% below its 10-year median of 41.23. GuruFocus rates HKSE:08247 with a GF Score™ of 37/100 and a GF Value™ of HK$0.44 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 193 Medical Diagnostics & Research companies, Biosino Bio-Technology and Science ranks worse than 64.25% on this metric.
HKSE:08247's Gross Margin % is ranked worse than 64.25% of 193
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.76
vs HKSE:08247: 38.48
Biosino Bio-Technology and Science had a gross margin of 37.91% for the quarter that ended in Dec. 2025 => Competition eroding margins
Biosino Bio-Technology and Science (HKSE:08247) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Biosino Bio-Technology and Science had a gross margin of 37.91% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Biosino Bio-Technology and Science Gross Margin % Related Terms
Biosino Bio-Technology and Science Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biosino Bio-Technology and Science Gross Margin % Chart
HKSE:08247 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biosino Bio-Technology and Science Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Biosino Bio-Technology and Science's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Biosino Bio-Technology and Science (HKSE:08247) has a Gross Margin % of 37.91% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Biosino Bio-Technology and Science and its competitors. This is near median its historical median of 41.23. Over the past decade, Biosino Bio-Technology and Science's Gross Margin % has ranged from 33.99 to 46.52. According to the industry distribution chart, Biosino Bio-Technology and Science ranks #124 out of 193 companies in the Medical Diagnostics & Research industry, placing it in the top 64.2%.
Is Biosino Bio-Technology and Science's Gross Margin % too high?
Biosino Bio-Technology and Science's current Gross Margin % of 37.91% is near median its 10-year median of 41.23. Over the past 10 years, this metric has ranged from a low of 33.99 to a high of 46.52. The Medical Diagnostics & Research industry median Gross Margin % is 50.76. Biosino Bio-Technology and Science's value of 37.91% is 25.3% below this industry median. Based on the distribution chart, Biosino Bio-Technology and Science ranks #124 out of 193 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Biosino Bio-Technology and Science has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biosino Bio-Technology and Science's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Biosino Bio-Technology and Science ranks #124 out of 193 companies for Gross Margin %. This places Biosino Bio-Technology and Science in the lower half of its industry. The industry median Gross Margin % is 50.76. Biosino Bio-Technology and Science's value of 37.91% is 25.3% below this benchmark. Historically, Biosino Bio-Technology and Science's own Gross Margin % has ranged from 33.99 to 46.52 over the past decade. While the company's 10-year median is 41.23 vs. the industry median of 50.76, Biosino Bio-Technology and Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.76, based on 193 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biosino Bio-Technology and Science's current Gross Margin % of 37.91% is 25.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Biosino Bio-Technology and Science and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biosino Bio-Technology and Science's current Gross Margin % is 37.91%, which is near median its own 10-year median of 41.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosino Bio-Technology and Science stock overvalued right now?
Based on GuruFocus' analysis, Biosino Bio-Technology and Science (HKSE:08247) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$3.16 — trading 618.2% above its estimated fair value. The current Gross Margin % is 37.91%, which is near median its 10-year median of 41.23 and 25.3% below the Medical Diagnostics & Research industry median of 50.76. Biosino Bio-Technology and Science's overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Biosino Bio-Technology and Science (HKSE:08247), the current Gross Margin % is 37.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biosino Bio-Technology and Science (HKSE:08247) Overvalued in 2026?
Based on GuruFocus' analysis, Biosino Bio-Technology and Science stock appears to be overvalued.
The current stock price of HK$3.16 is trading 618.2% above its estimated GF Value™ of HK$0.44.
GuruFocus considers Biosino Bio-Technology and Science to be Significantly Overvalued.
Key valuation signals for HKSE:08247:
Gross Margin %: 37.91% (near median its 10-year median of 41.23)
GF Value™: HK$0.44 vs. price of HK$3.16 (618.2% above fair value)
Industry Position: 25.3% below the Medical Diagnostics & Research median (#124 of 193)
No single metric tells the full story. See the HKSE:08247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of IVD reagent products. The company operates in a single segment, the in-vitro diagnostic products segment, which manufactures, sells, and distributes a variety of mono/double diagnostic products. Geographically, it generates the majority of the revenue from Mainland China.
37GF Score
Get the complete analysis for HKSE:08247
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08247 has been successfully added to your 
